The global pharmaceutical impurity synthesis and isolation services market size is calculated at USD 1.35 billion in 2025 and is forecasted to reach around USD 2.73 billion by 2034, accelerating at a CAGR of 8.12% from 2025 to 2034. The North America market size surpassed USD 430 million in 2024 and is expanding at a CAGR of 8.14% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Pharmaceutical Impurity Synthesis and Isolation Services Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Pharmaceutical Impurity Synthesis and Isolation Services Market, by Service
8.1.1. Analytical Services
8.1.1.1. Market Revenue and Forecast
8.1.2. Isolation Services
8.1.2.1. Market Revenue and Forecast
8.1.3. Synthesis Service
8.1.3.1. Market Revenue and Forecast
9.1. Pharmaceutical Impurity Synthesis and Isolation Services Market, by Impurity Type
9.1.1. Inorganic Impurities
9.1.1.1. Market Revenue and Forecast
9.1.2. Organic Impurities
9.1.2.1. Market Revenue and Forecast
9.1.3. Residual Solvents
9.1.3.1. Market Revenue and Forecast
10.1. Pharmaceutical Impurity Synthesis and Isolation Services Market, by Technique
10.1.1. Chromatography
10.1.1.1. Market Revenue and Forecast
10.1.2. Crystallization
10.1.2.1. Market Revenue and Forecast
10.1.3. Hyphenated Techniques
10.1.3.1. Market Revenue and Forecast
10.1.4. Spectroscopy
10.1.4.1. Market Revenue and Forecast
11.1. Pharmaceutical Impurity Synthesis and Isolation Services Market, by Application
11.1.1. Commercial Manufacturing
11.1.1.1. Market Revenue and Forecast
11.1.2. Drug Development
11.1.2.1. Market Revenue and Forecast
11.1.3. Quality Control
11.1.3.1. Market Revenue and Forecast
11.1.4. Regulatory Compliance
11.1.4.1. Market Revenue and Forecast
12.1. Pharmaceutical Impurity Synthesis and Isolation Services Market, by End Use
12.1.1. Biotech & Pharmaceutical Companies
12.1.1.1. Market Revenue and Forecast
12.1.2. Contract Research Organizations (CRO)
12.1.2.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Service
13.1.2. Market Revenue and Forecast, by Impurity Type
13.1.3. Market Revenue and Forecast, by Technique
13.1.4. Market Revenue and Forecast, by Application
13.1.5. Market Revenue and Forecast, by End Use
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Service
13.1.6.2. Market Revenue and Forecast, by Impurity Type
13.1.6.3. Market Revenue and Forecast, by Technique
13.1.6.4. Market Revenue and Forecast, by Application
13.1.6.5. Market Revenue and Forecast, by End Use
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Service
13.1.7.2. Market Revenue and Forecast, by Impurity Type
13.1.7.3. Market Revenue and Forecast, by Technique
13.1.7.4. Market Revenue and Forecast, by Application
13.1.7.5. Market Revenue and Forecast, by End Use
13.2. Europe
13.2.1. Market Revenue and Forecast, by Service
13.2.2. Market Revenue and Forecast, by Impurity Type
13.2.3. Market Revenue and Forecast, by Technique
13.2.4. Market Revenue and Forecast, by Application
13.2.5. Market Revenue and Forecast, by End Use
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Service
13.2.6.2. Market Revenue and Forecast, by Impurity Type
13.2.6.3. Market Revenue and Forecast, by Technique
13.2.7. Market Revenue and Forecast, by Application
13.2.8. Market Revenue and Forecast, by End Use
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Service
13.2.9.2. Market Revenue and Forecast, by Impurity Type
13.2.9.3. Market Revenue and Forecast, by Technique
13.2.10. Market Revenue and Forecast, by Application
13.2.11. Market Revenue and Forecast, by End Use
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Service
13.2.12.2. Market Revenue and Forecast, by Impurity Type
13.2.12.3. Market Revenue and Forecast, by Technique
13.2.12.4. Market Revenue and Forecast, by Application
13.2.13. Market Revenue and Forecast, by End Use
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Service
13.2.14.2. Market Revenue and Forecast, by Impurity Type
13.2.14.3. Market Revenue and Forecast, by Technique
13.2.14.4. Market Revenue and Forecast, by Application
13.2.15. Market Revenue and Forecast, by End Use
13.3. APAC
13.3.1. Market Revenue and Forecast, by Service
13.3.2. Market Revenue and Forecast, by Impurity Type
13.3.3. Market Revenue and Forecast, by Technique
13.3.4. Market Revenue and Forecast, by Application
13.3.5. Market Revenue and Forecast, by End Use
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Service
13.3.6.2. Market Revenue and Forecast, by Impurity Type
13.3.6.3. Market Revenue and Forecast, by Technique
13.3.6.4. Market Revenue and Forecast, by Application
13.3.7. Market Revenue and Forecast, by End Use
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Service
13.3.8.2. Market Revenue and Forecast, by Impurity Type
13.3.8.3. Market Revenue and Forecast, by Technique
13.3.8.4. Market Revenue and Forecast, by Application
13.3.9. Market Revenue and Forecast, by End Use
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Service
13.3.10.2. Market Revenue and Forecast, by Impurity Type
13.3.10.3. Market Revenue and Forecast, by Technique
13.3.10.4. Market Revenue and Forecast, by Application
13.3.10.5. Market Revenue and Forecast, by End Use
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Service
13.3.11.2. Market Revenue and Forecast, by Impurity Type
13.3.11.3. Market Revenue and Forecast, by Technique
13.3.11.4. Market Revenue and Forecast, by Application
13.3.11.5. Market Revenue and Forecast, by End Use
13.4. MEA
13.4.1. Market Revenue and Forecast, by Service
13.4.2. Market Revenue and Forecast, by Impurity Type
13.4.3. Market Revenue and Forecast, by Technique
13.4.4. Market Revenue and Forecast, by Application
13.4.5. Market Revenue and Forecast, by End Use
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Service
13.4.6.2. Market Revenue and Forecast, by Impurity Type
13.4.6.3. Market Revenue and Forecast, by Technique
13.4.6.4. Market Revenue and Forecast, by Application
13.4.7. Market Revenue and Forecast, by End Use
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Service
13.4.8.2. Market Revenue and Forecast, by Impurity Type
13.4.8.3. Market Revenue and Forecast, by Technique
13.4.8.4. Market Revenue and Forecast, by Application
13.4.9. Market Revenue and Forecast, by End Use
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Service
13.4.10.2. Market Revenue and Forecast, by Impurity Type
13.4.10.3. Market Revenue and Forecast, by Technique
13.4.10.4. Market Revenue and Forecast, by Application
13.4.10.5. Market Revenue and Forecast, by End Use
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Service
13.4.11.2. Market Revenue and Forecast, by Impurity Type
13.4.11.3. Market Revenue and Forecast, by Technique
13.4.11.4. Market Revenue and Forecast, by Application
13.4.11.5. Market Revenue and Forecast, by End Use
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Service
13.5.2. Market Revenue and Forecast, by Impurity Type
13.5.3. Market Revenue and Forecast, by Technique
13.5.4. Market Revenue and Forecast, by Application
13.5.5. Market Revenue and Forecast, by End Use
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Service
13.5.6.2. Market Revenue and Forecast, by Impurity Type
13.5.6.3. Market Revenue and Forecast, by Technique
13.5.6.4. Market Revenue and Forecast, by Application
13.5.7. Market Revenue and Forecast, by End Use
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Service
13.5.8.2. Market Revenue and Forecast, by Impurity Type
13.5.8.3. Market Revenue and Forecast, by Technique
13.5.8.4. Market Revenue and Forecast, by Application
13.5.8.5. Market Revenue and Forecast, by End Use
14.1. Almac Group
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Cambrex Corporation
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Catalent Inc
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Charles River Laboratories
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Eurofins Scientific
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Frontage Labs
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Intertek Group Plc
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Laboratory Corporation of America Holdings
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. PCI Pharma Services
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Pharmaron
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample